Agenus
Our goal is to treat cancers with novel combinations using our unique portfolio of checkpoint antibodies, tumor microenvironment modifiers, vaccines & adjuvants. Learn more
Launch date
Employees
Market cap
AUD198m
Enterprise valuation
AUD178m (Public information from Sep 2024)
Share price
$5.84 AGEN
Lexington Kentucky (HQ)
Authorizing premium user...